HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of cyclin-D1 in uveal malignant melanoma.

AbstractBACKGROUND:
Uveal malignant melanoma (MM) is characterized by a marked variability in biological behavior and by an unpredictable clinical course. Therefore the search for reliable prognostic parameters is active. In this study we investigated the immunohistochemical expression of cyclin D1, a cell cycle regulatory molecule, to analyze the possible significance of the protein in the prognostic evaluation of these neoplasms.
MATERIALS AND METHODS:
Forty-five selected uveal MM were incubated with the anti-cyclin D-1 antibody; the findings were compared with the follow-up data, with the cell type and with the largest tumor dimension.
RESULTS:
The overexpression of cyclin D1 was found to be inversely related to disease-free interval (p < 0.001) and to the spindle A/B tumors with good prognosis (p = 0.05). On the other hand, a direct correlation was found with epithelioid/spindle B melanomas with poor clinical course (p = 0.05) and with sclera infiltration (p = 0.01). No statistically significant relation emerged between cyclin D1 expression and LTD.
CONCLUSION:
These data may suggest a possible role of the overexpression of cyclin D1 in the tumorigenesis of uveal MM and in the prognostic evaluation of these tumors, representing a useful tool to subclassify lesions with similar morphological features.
AuthorsMaria Elena Errico, Stefania Staibano, Fausto Tranfa, Giulio Bonavolonta, Lorenzo Lo Muzio, Pasquale Somma, Antonio Lucariello, Gelsomina Mansueto, Antonella D'Aponte, Gerardo Ferrara, Gaetano De Rosa
JournalAnticancer research (Anticancer Res) 2003 May-Jun Vol. 23 Issue 3B Pg. 2701-6 ISSN: 0250-7005 [Print] Greece
PMID12894561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclin D1
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cyclin D1 (biosynthesis)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Melanoma (metabolism, pathology)
  • Middle Aged
  • Prognosis
  • Uveal Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: